• S2:E8 – Neurology Morning Commute: Multiple Sclerosis and the S1P Receptor Upgrade

  • Apr 11 2022
  • Length: 23 mins
  • Podcast

S2:E8 – Neurology Morning Commute: Multiple Sclerosis and the S1P Receptor Upgrade

  • Summary

  • In this episode, our faculty looks at the latest treatments for multiple sclerosis—the newest sphingosine-1-phosphate receptor modulators. What is their mechanism of action? Which patients would benefit from them, and how are side effects and toxicities managed with these latest treatment options?

    Visit www.morningcommutepodcast.com/ms8 to view the activity and CME/CE information, download the transcript, and complete the post-test and evaluation to earn CME/CE credit

    Show More Show Less
activate_samplebutton_t1

What listeners say about S2:E8 – Neurology Morning Commute: Multiple Sclerosis and the S1P Receptor Upgrade

Average Customer Ratings

Reviews - Please select the tabs below to change the source of reviews.

In the spirit of reconciliation, Audible acknowledges the Traditional Custodians of country throughout Australia and their connections to land, sea and community. We pay our respect to their elders past and present and extend that respect to all Aboriginal and Torres Strait Islander peoples today.